Sagimet Biosciences grants 34,300 inducement stock options to new hires

Sagimet Biosciences

Sagimet Biosciences

SGMT

0.00
  • Sagimet Biosciences set an inducement equity award covering 34,300 stock options for two newly hired employees.
  • Options were granted June 22, 2026 to buy Series A common stock at the June 22 Nasdaq closing price.
  • Awards carry a 10-year term; 25% vests after one year, with the balance vesting monthly over the next 36 months.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sagimet Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606222049PRIMZONEFULLFEED9750867) on June 23, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.